Vimarsana
Biggest News Aggregation in the World

Evaluating Effect News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluating Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluating Effect Today - Breaking & Trending Today

Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN - Vimarsana News

Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN

Published: November 4, 2023

Data from multiple presentations at ASN Kidney Week 2023 offer insight into the effects of atacicept in patients with IgA nephropathy as well as the design of the phase 3 trial, which is currently enrolling.

Source: hcplive.com
Related Topics:
United StatesRichard LafayetteAmerican Society Of Nephrology Kidney WeekStanford Glomerular Disease CenterAmerican SocietyNephrology Kidney WeekKidney WeekEvaluating EffectRenal Function PreservationIga NephropathyPaper PresentedVera TherapeuticsAsn Kidney WeekKidney Week 2023
Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting - Vimarsana News

Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting

Published: October 13, 2023

Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy Additional analysis of week 36 data from Phase 2b ORIGIN study show atacicept 150mg reduces serum...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesJoyce AllaireJonathan BarrattExchange CommissionUniversity Of LeicesterVera Therapeutics IncAmerican Society Of NephrologyAmerican Society Of Nephrology Kidney WeekIga NephropathyAmerican SocietyKidney WeekWeek Poster Presentation DetailsEvaluating EffectRenal Function PreservationMayer ProfessorRenal MedicineReduces Serum Gd IgaBiomarker AssociatedLong Term OutcomesContinued Protective TitersBalanced InfectionsInducing LigandPrivate Securities Litigation Reform ActNephrology Kidney Week